SCHEMBL1007806

SCHEMBL1007806

CC1(C)OB(c2ccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)cc2)OC1(C)C

nearest known ligand 0.76

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 13/20 0.76
LPL P06858 12/20 0.76
SNCA P37840 1/20 0.40
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
DGAT1 O75907 1/20 0.38
P4HB P07237 1/20 0.36
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13098741 0.94 LIPG (0.71) LIPGLPLSNCACA1CA2
SCHEMBL25770807 0.92 LIPG (0.65) LIPGLPLSNCACA1CA2
SCHEMBL29980865 0.92 LIPG (0.68) LIPGLPLSNCACA1CA2
SCHEMBL1935027 0.92 LIPG (0.68) LIPGLPLSNCACA1CA2
SCHEMBL12246537 0.91 LIPG (0.63) LIPGLPLSNCADGAT1P4HB
SCHEMBL17116862 0.90 LIPG (0.61) LIPGLPLSNCACA1CA2
SCHEMBL10457213 0.90 LIPG (0.69) LIPGLPLSNCACA1CA2
SCHEMBL14506120 0.89 LIPG (0.68) LIPGLPLSNCADGAT1IRAK4
SCHEMBL10457136 0.89 LIPG (0.72) LIPGLPLSNCACA1CA2
SCHEMBL13295622 0.89 LIPG (0.63) LIPGLPLSNCADGAT1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9028977-B2 Compound, method for preparing same and organic electronic device using same LG CHEM, LTD. (KR) 2015-05-12 US disclosed
US-9028977-B2 Compound, method for preparing same and organic electronic device using same LG CHEM, LTD. (KR) 2015-05-12 US disclosed
US-8053762-B2 Imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same LG CHEM, LTD. (KR) 2011-11-08 US disclosed
US-8053762-B2 Imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same LG CHEM, LTD. (KR) 2011-11-08 US disclosed
US-20110168992-A1 NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEM, LTD. (KR) 2011-07-14 US disclosed
US-20110168992-A1 NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEM, LTD. (KR) 2011-07-14 US disclosed
US-7875367-B2 cyclopentaphenanthrene-based compound which is adapted for both dry and wet processes, and has excellent thermal stability and good charge transport and emission characteristics SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-01-25 US disclosed
US-20090230855-A1 Novel organic compound and organic light emitting device comprising the same SAMSUNG ELECTRONICS CO., LTD., A CORPORATION CHARTERED IN AND EXISTING UNDER THE LAWS OF THE REPUBLIC OF KOREA (KR) 2009-09-17 US disclosed
US-20090230855-A1 Novel organic compound and organic light emitting device comprising the same SAMSUNG ELECTRONICS CO., LTD., A CORPORATION CHARTERED IN AND EXISTING UNDER THE LAWS OF THE REPUBLIC OF KOREA (KR) 2009-09-17 US disclosed
US-20080079356-A1 Organoelectroluminescent compound and organoelectroluminescent device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2008-04-03 US disclosed
US-20070131929-A1 Novel imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same LG CHEM. LTD. (KR) 2007-06-14 US disclosed
US-20070131929-A1 Novel imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same LG CHEM. LTD. (KR) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090230855-A1 Novel organic compound and organic light emitting device comprising the same ARL1, NR2E3, CRY2 LIPG 4113/4885LPL 2639/4885SNCA 1302/4885
US-20080079356-A1 Organoelectroluminescent compound and organoelectroluminescent device employing the same PPOX, EML4, ALPL LIPG 696/4885LPL 1705/4885SNCA 2014/4885
US-20110168992-A1 NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME OR10J3, USE1, NOTUM LIPG 1928/4885LPL 3043/4885SNCA 1457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.